FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 268 filers reported holding FATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31,079 | -55.5% | 14,660 | 0.0% | 0.00% | – |
Q2 2023 | $69,782 | -16.5% | 14,660 | 0.0% | 0.00% | – |
Q1 2023 | $83,562 | -43.5% | 14,660 | 0.0% | 0.00% | -100.0% |
Q4 2022 | $147,919 | -34.0% | 14,660 | +47.0% | 0.00% | 0.0% |
Q3 2022 | $224,000 | -9.3% | 9,975 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $247,000 | -36.2% | 9,975 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $387,000 | -50.5% | 9,975 | -25.3% | 0.00% | -50.0% |
Q4 2021 | $782,000 | +60.6% | 13,360 | +62.4% | 0.00% | +33.3% |
Q3 2021 | $487,000 | -31.9% | 8,225 | -0.2% | 0.00% | -25.0% |
Q2 2021 | $715,000 | +5.6% | 8,238 | +0.4% | 0.00% | 0.0% |
Q1 2021 | $677,000 | -21.6% | 8,206 | -13.6% | 0.00% | -20.0% |
Q4 2020 | $864,000 | +211.9% | 9,497 | +37.2% | 0.01% | +150.0% |
Q3 2020 | $277,000 | +16.4% | 6,924 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $238,000 | +107.0% | 6,924 | +33.7% | 0.00% | +100.0% |
Q1 2020 | $115,000 | +101.8% | 5,179 | +76.5% | 0.00% | – |
Q4 2019 | $57,000 | +23.9% | 2,934 | 0.0% | 0.00% | – |
Q3 2019 | $46,000 | -23.3% | 2,934 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $60,000 | +15.4% | 2,934 | 0.0% | 0.00% | – |
Q1 2019 | $52,000 | +4.0% | 2,934 | -24.1% | 0.00% | -100.0% |
Q4 2018 | $50,000 | +28.2% | 3,865 | +61.0% | 0.00% | – |
Q3 2018 | $39,000 | – | 2,401 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |